166 related articles for article (PubMed ID: 38006433)
21. Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma.
Chen XQ; Ma J; Xu D; Xiang ZL
BMC Bioinformatics; 2023 Jun; 24(1):270. PubMed ID: 37386390
[TBL] [Abstract][Full Text] [Related]
22. Focusing on scRNA-seq-Derived T Cell-Associated Genes to Identify Prognostic Signature and Immune Microenvironment Status in Low-Grade Glioma.
Wen J; Huang Q; Yao J; Wei W; Li Z; Zhang H; Chang S; Pei H; Cao Y; Li H
Mediators Inflamm; 2023; 2023():3648946. PubMed ID: 37292257
[TBL] [Abstract][Full Text] [Related]
23. Intra-tumor heterogeneity and prognostic risk signature for hepatocellular carcinoma based on single-cell analysis.
Liu C; Pu M; Ma Y; Wang C; Kong L; Zhang S; Zhao X; Lian X
Exp Biol Med (Maywood); 2022 Oct; 247(19):1741-1751. PubMed ID: 36330895
[TBL] [Abstract][Full Text] [Related]
24. Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma.
Su Z; He Y; You L; Zhang G; Chen J; Liu Z
Front Immunol; 2024; 15():1363834. PubMed ID: 38633247
[TBL] [Abstract][Full Text] [Related]
25. CD74
Xiao N; Li K; Zhu X; Xu B; Liu X; Lei M; Sun HC
Cancer Immunol Immunother; 2022 Jan; 71(1):57-69. PubMed ID: 34009409
[TBL] [Abstract][Full Text] [Related]
26. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
27. Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer.
Pang J; Yu Q; Chen Y; Yuan H; Sheng M; Tang W
J Transl Med; 2022 Nov; 20(1):531. PubMed ID: 36401283
[TBL] [Abstract][Full Text] [Related]
28. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
29. Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma.
Dai Z; Wang Y; Sun N; Zhang C
Front Immunol; 2023; 14():1299953. PubMed ID: 38274805
[TBL] [Abstract][Full Text] [Related]
30. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated endothelial cell prognostic risk model and tumor immune environment modulation in liver cancer based on single-cell and bulk RNA sequencing: Experimental verification.
Yang D; Kuang T; Zhou Y; Su Y; Shen J; Yu B; Zhao K; Ding Y
Int Immunopharmacol; 2023 Nov; 124(Pt A):110870. PubMed ID: 37690233
[TBL] [Abstract][Full Text] [Related]
32. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework.
Feng Q; Huang Z; Song L; Wang L; Lu H; Wu L
Eur J Med Res; 2023 Aug; 28(1):306. PubMed ID: 37649103
[TBL] [Abstract][Full Text] [Related]
33. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
34. Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma.
Zhu L; Lou Y; Xiao Q; Wang L; Chen G; Yang W; Wang T
Biochem Genet; 2024 Apr; 62(2):698-717. PubMed ID: 37405532
[TBL] [Abstract][Full Text] [Related]
35. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
36. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
37. Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and immunotherapy response in hepatocellular carcinoma.
Liu T; Li C; Zhang J; Hu H; Li C
Front Immunol; 2023; 14():1237350. PubMed ID: 37575252
[TBL] [Abstract][Full Text] [Related]
38. Deep dissection of stemness-related hierarchies in hepatocellular carcinoma.
Liang R; Hong W; Zhang Y; Ma D; Li J; Shi Y; Luo Q; Du S; Song G
J Transl Med; 2023 Sep; 21(1):631. PubMed ID: 37717019
[TBL] [Abstract][Full Text] [Related]
39. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
[TBL] [Abstract][Full Text] [Related]
40. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
